PBT2 and zinc work together to fight antibiotic resistance, page-73

porhon, sure it would. I think there is enough pressure for this management, IMO this will or perhaps at least should change everything what was planned with the Sinclair deal.
IMO the first thing is to get extension to the patent or in fact to get a totally a new patent for PBT2 to get much longer lasting patent. This is not easy and it needs to be filed in few months. The owners of this future patent needs to be clear, what was the role of the inventors and their universities. Negotiations will take some time. I would think that when the ownership of this new patent application is clear and when the application has been sent, Prana's value is more clear. But IMO the present value is not right and I would not mind some activity on the media arena.
If the value of Prana would be some  only 5-10 times more with this news the value of possible Sinclair deal would be 0.  So perhaps we should follow your suggestion. In fact the company management should do it if they want to increase the company value as they have promised.